Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent …

Interpretation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serosurveillance studies is limited by poorly defined performance of antibody assays over time in …

Encapsulation of human embryonic stem-cell-differentiated beta cell clusters (hES-βC) holds
great promise for cell replacement therapy for the treatment of diabetics without the need …

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
around the world, there is an urgent need for new assay formats to characterize the humoral …

Glioblastoma is a particularly challenging cancer, as there are currently limited options for
treatment. New delivery routes are being explored, including direct intratumoral injection via …

RNA interference (RNAi) therapeutics are an emerging class of medicines that selectively
target mRNA transcripts to silence protein production and combat disease. Despite the recent …

Methods for selective covalent modification of amino acids on proteins can enable a diverse
array of applications, spanning probes and modulators of protein function to proteomics 1 , 2 …

The field of chemical modification of proteins has been dominated by random modification of
lysines or more site-specific labeling of cysteines, each with attendant challenges. Recently…

A serious public health crisis is currently unfolding due to the SARS-CoV-2 pandemic. SARS-CoV-2
viral entry depends on an interaction between the receptor binding domain of the …

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most
directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-…